As one of the representative substrates of A-to-I RNA editing identified in 2005 [10], BLCAP was reported to show an obvious difference in editing level between tumor and normal tissues, with a tumor-specific editing pattern in lung cancer, oral cavity cancer, brain cancer and urinary bladder cancer [11, 12]. The gene discussed is BLCAP; the disease is urinary bladder cancer.